290 related articles for article (PubMed ID: 15228171)
21. Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel.
Andriguetti NB; Raymundo S; Antunes MV; Perassolo MS; Verza SG; Suyenaga ES; Linden R
Curr Med Chem; 2017; 24(33):3559-3582. PubMed ID: 28641556
[TBL] [Abstract][Full Text] [Related]
22. Cancer pharmacogenetics.
Marsh S; McLeod HL
Br J Cancer; 2004 Jan; 90(1):8-11. PubMed ID: 14710198
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic and pharmacogenetic determinants and considerations in chemotherapy selection and dosing in infants.
Hutson JR; Weitzman S; Schechter T; Arceci RJ; Kim RB; Finkelstein Y
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):709-22. PubMed ID: 22509821
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacogenetics and pharmacogenomics of cancers].
Robert J
Pathol Biol (Paris); 2004 Jul; 52(6):332-7. PubMed ID: 15261376
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome P450 pharmacogenetics and cancer.
Rodriguez-Antona C; Ingelman-Sundberg M
Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacogenetics in oncology].
Morán González D; Jiménez Cabrera S; Domínguez-Gil Hurlé A
Med Clin (Barc); 2008 Jul; 131(5):184-95. PubMed ID: 18674490
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenetics in gastrointestinal tumors.
Stöhlmacher J
Onkologie; 2005 Aug; 28(8-9):435-40. PubMed ID: 16160407
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetics of fluoropyrimidine and cisplatin. A future application to gastric cancer treatment.
Shimoyama S
J Gastroenterol Hepatol; 2009 Jun; 24(6):970-81. PubMed ID: 19638079
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics and cancer therapy.
Relling MV; Dervieux T
Nat Rev Cancer; 2001 Nov; 1(2):99-108. PubMed ID: 11905809
[TBL] [Abstract][Full Text] [Related]
30. Cancer pharmacogenomics: international trends.
Yamayoshi Y; Iida E; Tanigawara Y
Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
[TBL] [Abstract][Full Text] [Related]
31. [Value and applications of pharmacogenetics in oncology and hematology].
Albin N; Massade L; Gouyette A
Bull Cancer; 1997 Jun; 84(6):643-51. PubMed ID: 9295869
[TBL] [Abstract][Full Text] [Related]
32. Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.
Narendra G; Choudhary S; Raju B; Verma H; Silakari O
Clin Pharmacokinet; 2022 Nov; 61(11):1495-1517. PubMed ID: 36180817
[TBL] [Abstract][Full Text] [Related]
33. Genetic factors influencing pyrimidine-antagonist chemotherapy.
Maring JG; Groen HJ; Wachters FM; Uges DR; de Vries EG
Pharmacogenomics J; 2005; 5(4):226-43. PubMed ID: 16041392
[TBL] [Abstract][Full Text] [Related]
34. Using genetic variation to optimize cancer chemotherapy.
McLeod HL; Papageorgio C; Watters JW
Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
[TBL] [Abstract][Full Text] [Related]
35. Part 4: pharmacogenetic variability in anticancer pharmacodynamic drug effects.
Deenen MJ; Cats A; Beijnen JH; Schellens JH
Oncologist; 2011; 16(7):1006-20. PubMed ID: 21659612
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications.
Dervieux T; Meshkin B; Neri B
Mutat Res; 2005 Jun; 573(1-2):180-94. PubMed ID: 15829247
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenomics of cancer chemotherapy-induced toxicity.
Miller CR; McLeod HL
J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
[TBL] [Abstract][Full Text] [Related]
38. The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil.
Diasio RB; Johnson MR
Pharmacology; 2000 Sep; 61(3):199-203. PubMed ID: 10971206
[TBL] [Abstract][Full Text] [Related]
39. CYP450 pharmacogenetics for personalizing cancer therapy.
van Schaik RH
Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
Danesi R; De Braud F; Fogli S; Di Paolo A; Del Tacca M
Trends Pharmacol Sci; 2001 Aug; 22(8):420-6. PubMed ID: 11479005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
